Literature DB >> 8956704

NHS breast screening programme: is the high incidence of interval cancers inevitable?

D Asbury1, C R Boggis, D Sheals, A G Threlfall, C B Woodman.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8956704      PMCID： PMC2352925          DOI： 10.1136/bmj.313.7069.1369

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  What should be done about interval breast cancers?

Authors:  S Field; M J Michell; M G Wallis; A R Wilson
Journal:  BMJ       Date:  1995-01-28

2.  Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.

Authors:  N Day; J McCann; C Camilleri-Ferrante; P Britton; G Hurst; S Cush; S Duffy
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

3.  Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.

Authors:  J Frisell; A von Rosen; M Wiege; B Nilsson; S Goldman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.

Authors:  C B Woodman; A G Threlfall; C R Boggis; P Prior
Journal:  BMJ       Date:  1995-01-28

5.  The occurrence of interval cancers in the Nijmegen screening programme.

Authors:  P H Peeters; A L Verbeek; J H Hendriks; R Holland; M Mravunac; G P Vooijs
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640
  5 in total
  3 in total

1.  Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.

Authors:  Alessandra Ravaioli; Flavia Foca; Americo Colamartini; Fabio Falcini; Carlo Naldoni; Alba C Finarelli; Priscilla Sassoli de Bianchi; Lauro Bucchi
Journal:  BMC Med       Date:  2010-02-01       Impact factor: 8.775

2.  Rate and classification of interval cancers in the breast screening programme.

Authors:  P A Sylvester; E Kutt; A Baird; M N Vipond; A J Webb; J R Farndon
Journal:  Ann R Coll Surg Engl       Date:  1997-07       Impact factor: 1.891

3.  Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom.

Authors:  G A Miltenburg; P H Peeters; J Fracheboud; H J Collette
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.